Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00114478Phase 4Unknown
Phase 4, randomised, double-blind trial in bronchiolitis comparing Epinephrine with Albuterol (2 arms). Primary endpoint: Hospital Admission Rate at 72 hours. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00114478.